
Viatris and Idorsia have announced that they have entered into agreements for a significant global research and development collaboration. Under …

The name for the new company emerging out of the merger between Pharma firm Mylan and Pfizer division Upjohn has …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

